Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT07235865

Non-Invasive Diagnosis and Monitoring of Cardiac Masses by Liquid Biopsy

Sponsor: Niguarda Hospital

View on ClinicalTrials.gov

Summary

This is a nonprofit, observational, prospective and retrospective,multicenter study in a population of young and adult patients ≥12 years with a diagnosis of a cardiac mass. The study will include both patients with masses of unknown pathological diagnosis and patients with a known histology of benign or malignant tumors. We predict a case-control allocation ratio of 1:1 between cardiac malignant tumors and benign lesions. Peripheral blood will be collected at participating centers during routine venipuncture,processed and then shipped for liquid biopsy ctDNA NGS analyses. If available, in malignant cases, matched tumor tissue samples collected as per clinical practice solid biopsies or surgery will be used for analyses. Longitudinal tracking through serial blood draws could be performed in selected cases of patients with cardiac malignancies who receive cancer treatment

Official title: Non-Invasive Diagnosis and Monitoring of Cardiac Masses by Liquid Biopsy: The CarMA Study

Key Details

Gender

All

Age Range

12 Years - Any

Study Type

OBSERVATIONAL

Enrollment

26

Start Date

2024-07-25

Completion Date

2025-12-25

Last Updated

2025-11-19

Healthy Volunteers

No

Conditions

Interventions

GENETIC

NGS-guided regimen: Regimen A

Liquid biopsy, consisting of a venous blood sample, will be collected during routine venipuncture

Locations (1)

Niguarda Hospital

Milan, Italia, Italy